Previous 10 | Next 10 |
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“ Profound ” or the “ Company ”) is pleased to announce the commencement of an underwritten public offering in the United States of common shares (the “ Common Sh...
2023-12-23 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-01 15:27:39 ET More on Profound Medical Profound Medical Corp. (PROF) Q3 2023 Earnings Call Transcript Profound Medical receives FDA 510(k) clearance for TULSA-PRO Thermal Boost Profound Medical gains as investment bank Raymond James raises rating to Strong B...
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
2023-11-04 11:45:25 ET Profound Medical Corp. (PROF) Q3 2023 Earnings Conference Call November 02, 2023 16:30 P.M. ET Company Participants Stephen Kilmer - IR Arun Menawat - Chairman and CEO Rashed Dewan - CFO Conference Call Participants Rahul Saruga...
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, an...
2023-11-02 17:07:40 ET Profound Medical press release ( NASDAQ: PROF ): Q3 GAAP EPS of -$0.26 beats by $0.07 . Revenue of $1.7M (-16.3% Y/Y) misses by $0.4M . As at September 30, 2023, Profound had cash of approximately $33.6 million. For further details ...
TORONTO, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, to...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Profound Medical Corp. (PROF) is expected to report $-0.31 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PROF Stock Symbol:
NYSE Market:
Profound Medical Corp. Website:
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...
2024-07-03 23:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 00:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...